Twist Bioscience Corporation
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-base…
Medical - Diagnostics & Research
US, South San Francisco [HQ]
Financials
Analysts
Wall Street · Earnings · Institutional SentimentA comprehensive analysis section that covers unveiling insights about Twist Bioscience Corporation's gradings, price targets and earnings estimates. None
| FY | EPS | Revenue [mil.] | Profit [mil.] | EBITDA [mil.] | EBIT [mil.] | Expenses · SGA [mil.] | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E | E | E | E | E | E | |||||||
| 2018 | -2.6800 | -2.447 | 25 | 24 | -71 | -139 | -63 | -23 | -70 | -23 | 43 | 26 |
| 2019 | -3.9200 | -3.778 | 54 | 52 | -107 | -214 | -99 | -50 | -108 | -51 | 80 | 57 |
| 2020 | -3.5700 | -3.546 | 90 | 80 | -139 | -87 | -132 | -79 | -117 | -121 | 103 | 88 |
| 2021 | -3.1500 | -3.136 | 132 | 130 | -152 | -164 | -143 | -163 | -153 | -177 | 135 | 143 |
| 2022 | - | -4.465 | - | 179 | - | -214 | - | -209 | - | -228 | - | 168 |
| 2023 | -3.6000 | -3.718 | 245 | 241 | -204 | -205 | -174 | -230 | -217 | -251 | 189 | 224 |
| 2024 | -3.6000 | -3.717 | 312 | 310 | -208 | -215 | -176 | -262 | -220 | -279 | 218 | 291 |
| 2025 | - | -2.252 | - | 373 | - | -128 | - | -314 | - | -335 | - | 350 |
| 2026 | - | 3.F8X/td> | - | 3.F8X/td> | - | 3.F8X/td> | - | 3.F81/td> | - | 3.F81 | - | 3.F81 |
| 2027 | - | 2.F9X/td> | - | 2.F9X/td> | - | 2.F9X/td> | - | 2.F91/td> | - | 2.F91 | - | 2.F91 |
| 2028 | - | 1.F10X/td> | - | 1.F10X/td> | - | 1.F10X/td> | - | 1.F101/td> | - | 1.F101 | - | 1.F101 |
| 2029 | - | 0.F11X/td> | - | 0.F11X/td> | - | 0.F11X/td> | - | 0.F111/td> | - | 0.F111 | - | 0.F111 |